Natixis’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
|
|||||
|
2025
Q1 | $4.08M | Buy |
|
|||||
|
2024
Q4 | $4.34M | Sell |
|
|||||
|
2024
Q3 | $22.6M | Buy |
|
|||||
|
2024
Q2 | $24.9M | Buy |
|
|||||
|
2024
Q1 | $21.9M | Buy |
|
|||||
|
2023
Q4 | $17.4M | Buy |
|
|||||
|
2023
Q3 | $5.53M | Sell |
|
|||||
|
2023
Q2 | $9.1M | Buy |
|
|||||
|
2023
Q1 | $4.52M | Sell |
|
|||||
|
2022
Q4 | $40.2M | Buy |
|
|||||
|
2022
Q3 | $24.6M | Sell |
|
|||||
|
2022
Q2 | $28M | Buy |
|
|||||
|
2022
Q1 | $19.6M | Sell |
|
|||||
|
2021
Q4 | $51.7M | Buy |
|
|||||
|
2021
Q3 | $25.1M | Sell |
|
|||||
|
2021
Q2 | $37.2M | Buy |
|
|||||
|
2021
Q1 | $12.1M | Sell |
|
|||||
|
2020
Q4 | $21.2M | Buy |
|
|||||
|
2020
Q3 | $4.8M | Sell |
|
|||||
|
2020
Q2 | $8.69M | Sell |
|
|||||
|
2020
Q1 | $23.2M | Sell |
|
|||||
|
2019
Q4 | $54.3M | Buy |
|
|||||
|
2019
Q3 | $37.2M | Buy |
|
|||||
|
2019
Q2 | $33.4M | Sell |
|
|||||
|
2019
Q1 | $63.3M | Buy |
|
|||||
|
2018
Q4 | $10.6M | Sell |
|
|||||
|
2018
Q3 | $34.3M | Sell |
|
|||||
|
2018
Q2 | $40.9M | Buy |
|
|||||
|
2018
Q1 | $35.9M | Buy |
|
|||||
|
2017
Q4 | $31.5M | Buy |
|
|||||
|
2017
Q3 | $22.6M | Sell |
|
|||||
|
2017
Q2 | $60M | Buy |
|
|||||
|
2017
Q1 | $55.1M | Buy |
|
|||||
|
2016
Q4 | $53.1M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $30.5M | Buy |
|
|||||
|
2016
Q1 | $32.6M | Sell |
|
|||||
|
2015
Q4 | $46M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $315K | Sell |
|
|||||
|
2015
Q1 | $13.2M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $1.04M | Sell |
|
|||||
|
2014
Q2 | $11.4M | Sell |
|
|||||
|
2014
Q1 | $17.8M | Sell |
|
|||||
|
2013
Q4 | $56.1M | Sell |
|
|||||
|
2013
Q3 | $53.2M | Buy |
|
|||||
|
2013
Q2 | $23.4M | Buy |
|